As this long-acting amylin analogue advances through Phase 3 clinical trials, having a comprehensive reference for proper administration protocols has never been more critical
Protective Effects of Hexarelin and JMV2894 in a research subjects Neuroblastoma Cell [PMID: 36674509] Laboratory literature summary: Protective Effects of Hexarelin and JMV2894 in a research subjects Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein

Ingredients Water, Butylene Glycol, Glycerin, Methylpropanediol, Niacinamide, Propanediol, 1,2-Hexanediol, Betaine, Carbomer, Hydroxyacetophe- none, Tromethamine, Glycereth-25 PCA Isostearate, Sea Water, Diphenyl Dimethicone, Panthenol, Triethylhexanoin, Ethylhexylglycerin, Xanthan Gum, Adenosine, Disodium EDTA, Fragrance, Hydrogenated Lecithin, Polyglyceryl-10 Oleate, Biosaccharide Gum-1, Glutathione, Hyaluronic Acid, Hydrolyzed Hyaluronic Acid, Sodium DNA, Sodium Hyaluronate, Stellaria Media (Chickweed) Extract, Lactobacillus Ferment, Aloe Barbadensis Leaf Extract, Dioscorea Japonica Root Extract, Hibiscus Esculentus Fruit Extract, Malva Sylvestris (Mallow) Extract, Saccharide Isomerate, Alanine, Glutamic Acid, Glycine, Serine, Threonine, Calendula Officinalis Flower Extract, PCA, Hamamelis Virginiana (Witch Hazel) Leaf Extract, Centella Asiatica Extract, Citric Acid, Sodium Citrate, Ascorbic Acid, Helianthus Annuus (Sunflower) Seed Oil, Tranexamic Acid, Caprylic/Capric Triglyceride, Ceramide NP Content 150 ml / 1.07 fl oz For Topical and Cosmetic Use Only

30 Servings per container